Alzheimer's Drug Discovery Foundation

04/04/2023

The is thrilled and humbled to share that the family has committed a historic $200 million, a gift that will support development of novel methods to prevent, diagnose, treat, and cure disease – and will ultimately allow the ADDF to change the way the world ages. This incredible contribution will propel the ADDF forward as we help bring to market a new generation of drugs based on the that can be used in combination with other therapies targeting a whole host of targets, including anti-amyloid therapies, to stop Alzheimer’s in its tracks. We are already well on our way to this future, with 75% of clinical trials the current pipeline aimed at diverse targets and new in development to complement these drugs. Within the next 15 years, we will accomplish the goal the ADDF was founded on in honor of 25 years ago and transform Alzheimer’s into a curable and preventable disease. Learn more: https://bit.ly/3G3gNNG

11/05/2022

Wishing our ADDF marathon team good luck tomorrow in the ! Thanks to their efforts, we are moving closer to finding a cure for 💜

06/03/2022

The ADDF hosted our Twelfth Annual Great Ladies Luncheon and Fashion Show honoring Andrea Mitchell, NBC News Chief Foreign Affairs Correspondent and Chief Washington Correspondent and Host of Andrea Mitchell Reports on MSNBC, with the 2022 Great Ladies Award and Eli Lilly and Company with the 2022 Estelle Gelman Award, which was accepted by Anne White, Senior Vice President and President, Lilly Neuroscience.

The event raised more than $550,000, every dollar of which will go directly toward accelerating the development of drugs to prevent, treat and cure disease. In an afternoon of science and , the event celebrated the incredible advocacy and support of the ADDF’s mission by this year’s honorees.

The event also featured a special preview of ’s Fall 2022 Collection in collaboration with our fashion partner , introduced by , Co-Creative Director of Oscar de la Renta, with remarks by Eliza Bolen, Executive Vice President of Oscar de la Renta.
📸

01/18/2022

"We're opening the door right now to a new era of ," says ADDF Co-Founder and Chief Science Officer Dr. Howard Fillit.

In an interview with USA TODAY, Dr. Fillit offered insights on why he and other experts are more optimistic than ever about the drug pipeline. Much of this optimism is because of the biology of aging, a theory pioneered by the ADDF and now widely accepted by the field at large, which focuses on developing treatments that address the many biological pathways that go awry during the process. Like with , 's will need to be treated through multiple approaches.

Learn more!

Even as the controversial new drug Aduhelm offers hope for those with Alzheimer's, researchers are exploring new kinds of treatment approaches.

09/27/2021

We are proud to be working alongside Bill Gates as we advance new digital technologies to detect : https://gatesnot.es/2ZrH85k.

New breakthroughs in Alzheimer’s diagnostics may someday soon let us substantially alter the course of the disease.

09/20/2021

As we commemorate , we are proud to share the future of 's research is bright. Much of our optimism derives from the incredible progress we've made in . We now have several new promising tests in the pipeline thanks to the Alzheimer's Drug Discovery Foundation Diagnostics Accelerator (DxA), a partnership spearheaded by co-founder Leonard Lauder and Bill Gates. The DxA is a global research initiative dedicated to fast-track the development of affordable and accessible diagnostic tools and .

In a Gates Notes post, provides updates on diagnostic tests that that may be soon available , including a simple blood test in development at University of Gothenburg, an eye test to scan your eyes for early signs of Alzheimer’s led by a team at the University of Washington, and digital tests being developed by Cogstate and Altoida.

Today and every day, we are grateful for collaborations like the DxA that are brining us closer to new developing new therapies for patients and their families. Hope IS on the horizon: https://gatesnot.es/3tVgCMY.

New breakthroughs in Alzheimer’s diagnostics may someday soon let us substantially alter the course of the disease.

06/08/2021

The approval reflects a period progress and innovation in 's research. With over 120 Alzheimer's clinical trials underway, Aducanumab will be one of many therapies used to combat this disease.

In a piece for Fox News Opinion, the Alzheimer's Drug Discovery Foundation's Chief Science Officer, Dr. Howard Fillit speaks to the diversity of the pipeline, which will lead to treatments that tackle various aging pathways. “I’ve firmly landed on the side of hope and excitement for what this milestone promises for the future," wrote Dr. Fillit.

Many patient advocacy groups representing the 6 million Americans suffering from Alzheimer’s disease are hailing the FDA’s approval of a new treatment for Alzheimer’s, aducanamab – the first since 2003.

06/07/2021

: The FDA approved Biogen's , the first-ever disease modifying therapy for patients. The 's Dr. Howard Fillit weighs in on how this impacts the Alzheimer's pipeline and what's to come: https://bit.ly/2T3suhy

05/26/2021

Did you know contain many compounds that may benefit you ? These include anthocyanins, which give blueberries their dark blue color and are reported to have and anti-inflammatory properties. Learn more at Cognitive Vitality: https://bit.ly/34dJF2m

05/25/2021

Want to learn more about the DASH diet, MIND diet, and more? The ADDF's was included as a featured resource in a recent Home Care Assistance blog on the best diets for :

Changing eating habits takes time but can improve overall brain and heart health. Learn a few ways you can include healthier ingredients into your diet.

05/09/2021

Happy to all of the women and families who have been touched by Alzheimer's disease.

Women are more than twice as likely as men to develop Alzheimer's and days like today remind us why the 's mission to discover and develop drugs to treat, prevent and cure this disease is so important. Together, we can conquer Alzheimer's for all of the women in our lives.

05/07/2021

Mark your calendar for May 10 at 7pm EST and join the at our 14th Annual Connoisseur’s Event! With a special performance by legend and advocate Andrea Bocelli, an art preview from Sotheby's, and honoring two pillars in the ’s community, David and Dagmar Dolby, we are looking forward to a wonderful evening that benefits Alzheimer’s ! Register here: https://bit.ly/3b2qe0a